Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism Wnt signalling pathway inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H34N4O6 |
InChIKeyCYIHQUXKBWFESS-IYARVYRRSA-N |
CAS Registry1287727-28-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | IT | 01 May 2015 |